IPI Legacy Liquidation Co
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | |
|---|---|---|---|
| Revenue | $12.7M | $668,000 | $15.0M |
| Operating income | −$83.2M | −$71.5M | −$45.3M |
| Net income | −$106.3M | −$76.5M | −$45.8M |
| Total assets | $88.5M | $97.9M | $12.1M |
| Total liabilities | $132.7M | $45.4M | $18.5M |
| Equity | −$44.2M | $52.5M | −$133.5M |
| EPS (diluted) | $-4.53 | $-5.25 | — |
| Shares out. | 23.1M | 23.1M | 755,478 |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −657.5%
- Net margin
- −840.3%
- Return on equity
- 240.8%
- Return on assets
- −120.1%
- Return on capital (ROCE)
- −125.3%
- Liabilities / assets
- 149.9%
- Debt / equity
- —
- Book value / share
- $-1.91
- Revenue growth (YoY)
- 1794.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -14.21distress
- Accruals / assets
- −14.3%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 4 warning● 3 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 15, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Amended charter or bylawsMar 12, 2024
- Entered a material agreement · Bankruptcy or receivership · Completed an acquisition or disposition · Director / officer changeFeb 14, 2024
- Other material eventJan 2, 2024
- Entered a material agreement · Bankruptcy or receivership · Debt acceleration / triggering event · Director / officer change · Regulation FD disclosure · Other material eventDec 20, 2023
- Delisting / listing-standard noticeDec 18, 2023
- Director / officer changeDec 4, 2023
- Director / officer changeNov 14, 2023
- Director / officer changeNov 2, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.